DE2961352D1 - 4-phenyl-thiazolyl-2-oxamate derivatives, their preparation and their use in the treatment of asthma - Google Patents

4-phenyl-thiazolyl-2-oxamate derivatives, their preparation and their use in the treatment of asthma

Info

Publication number
DE2961352D1
DE2961352D1 DE7979400293T DE2961352T DE2961352D1 DE 2961352 D1 DE2961352 D1 DE 2961352D1 DE 7979400293 T DE7979400293 T DE 7979400293T DE 2961352 T DE2961352 T DE 2961352T DE 2961352 D1 DE2961352 D1 DE 2961352D1
Authority
DE
Germany
Prior art keywords
thiazolyl
asthma
phenyl
treatment
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE7979400293T
Other languages
English (en)
Inventor
Henri Cousse
Gilbert Mouzin
Jean-Pierre Tarayre
Silvano Casadio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre SA
Original Assignee
Pierre Fabre SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre SA filed Critical Pierre Fabre SA
Application granted granted Critical
Publication of DE2961352D1 publication Critical patent/DE2961352D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DE7979400293T 1978-06-19 1979-05-09 4-phenyl-thiazolyl-2-oxamate derivatives, their preparation and their use in the treatment of asthma Expired DE2961352D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7818500A FR2429210A1 (fr) 1978-06-19 1978-06-19 Derives de phenyl-4 thiazolyl-2 oxamates utiles dans le traitement de l'asthme

Publications (1)

Publication Number Publication Date
DE2961352D1 true DE2961352D1 (en) 1982-01-21

Family

ID=9209775

Family Applications (1)

Application Number Title Priority Date Filing Date
DE7979400293T Expired DE2961352D1 (en) 1978-06-19 1979-05-09 4-phenyl-thiazolyl-2-oxamate derivatives, their preparation and their use in the treatment of asthma

Country Status (8)

Country Link
US (1) US4246271A (de)
EP (1) EP0006368B1 (de)
JP (1) JPS552684A (de)
AT (1) ATE407T1 (de)
CA (1) CA1231952A (de)
DE (1) DE2961352D1 (de)
ES (1) ES481633A1 (de)
FR (1) FR2429210A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2828091A1 (de) * 1978-06-27 1980-01-10 Boehringer Sohn Ingelheim 4-substituierte thiazoloxamsaeuren sowie ihre salze und ester
US4321372A (en) * 1980-06-16 1982-03-23 Pfizer Inc. Antiulcer thiazol-2-ylcarbamoyl-carboxylic acids, esters and amides
DE3027527A1 (de) * 1980-07-19 1982-02-18 Basf Ag, 6700 Ludwigshafen Neue oxamidsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel
FR2494272A1 (fr) * 1980-11-19 1982-05-21 Fabre Sa Pierre Derives de l'acide thiazolyl-2 oxamique substitues en position 4 par un radical thienyle ou furyle, leur preparation et leur utilisation comme medicaments
DE3135250A1 (de) * 1981-09-05 1983-03-17 Basf Ag, 6700 Ludwigshafen Tricyclische thiazolyloxamate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel
IT1183061B (it) * 1984-07-31 1987-10-05 Zambon Spa Composti dotati di attivita'antiallergica
DE3503773A1 (de) * 1985-02-05 1986-08-07 Basf Ag, 6700 Ludwigshafen Thiazolylamide, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
IT1204960B (it) * 1987-03-25 1989-03-10 Zambon Farmaceutici Spa Composti dotati di attivita' antiallergica
DE3807232A1 (de) * 1988-03-05 1989-09-14 Bayer Ag Substituierte acrylsaeureester
JPH0667836B2 (ja) * 1989-03-01 1994-08-31 東洋紡績株式会社 アミド系化合物からなる抗アレルギー剤
FR2671552B1 (fr) * 1991-01-15 1993-05-07 Pf Medicament Procede de preparation de thiazolyl-2 oxamates d'alkyle.
WO1993000342A1 (en) * 1991-06-21 1993-01-07 Boehringer Mannheim Italia S.P.A. 2-amino-4-aryl-thiazoles with antiasthmatic and anti-inflammatory activities on the respiratory tract
JP2510110B2 (ja) * 1992-04-07 1996-06-26 日本航空電子工業株式会社 電子部品用導体の製造方法
WO2000076513A1 (en) * 1999-06-11 2000-12-21 Merck & Co., Inc. Cyclopentyl modulators of chemokine receptor activity
AR038703A1 (es) * 2002-02-28 2005-01-26 Novartis Ag Derivados de 5-feniltiazol y uso como inhibidor de quinasa p i 3

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH486481A (de) * 1965-03-05 1970-02-28 Ciba Geigy Verfahren zur Herstellung neuer Nitrothiazolverbindungen
US4054666A (en) * 1973-03-23 1977-10-18 American Home Products Corporation Compositions and methods of treating immediate hypersensitivity reactions with thiazolyl oxamic acid derivatives
US3966965A (en) * 1973-03-23 1976-06-29 American Home Products Corporation Oxamic acid derivatives for the prevention of immediate type hypersensitivity reactions

Also Published As

Publication number Publication date
ATE407T1 (de) 1981-12-15
FR2429210B1 (de) 1980-10-31
JPS552684A (en) 1980-01-10
US4246271A (en) 1981-01-20
EP0006368A1 (de) 1980-01-09
JPS6251272B2 (de) 1987-10-29
FR2429210A1 (fr) 1980-01-18
EP0006368B1 (de) 1981-11-18
CA1231952A (fr) 1988-01-26
ES481633A1 (es) 1980-02-16

Similar Documents

Publication Publication Date Title
DE2961352D1 (en) 4-phenyl-thiazolyl-2-oxamate derivatives, their preparation and their use in the treatment of asthma
DK0468012T3 (da) 17beta-substituerede 4-aza-5alfa-androstan-3-on-derivater og fremgangsmåde til fremstilling deraf
HK1013993A1 (en) Novel carbamates and ureas as modifiers of multi-drug resistance
FI913478A0 (fi) Diazinderivat.
NO161910C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetralinderivater.
DK505983A (da) Imidazolylalkylthienyl-tetrahydropyridaziner og fremgangsmaade til fremstilling deraf
NO881921D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive osid-derivater.
ES8201572A1 (es) Procedimiento de preparar derivados propanolaminicos
NO304598B1 (no) Forgrenet-amino-substituerte tiazoler, anvendelse av dem og farmas°ytiske blandinger inneholdende dem
SE7600846L (sv) Forfarande for framstellning av 1-aryloxi-3-n-substituerade aminopropanderivat
IT7830479A0 (it) Composti di formula pb2(m2-xpbx)o7-y in cui m e' ru, ir, o loro miscele e metodo di preparazione.
ES507807A0 (es) Procedimiento para la obtencion de derivados triciclicos de citosina.
NO885386D0 (no) Bisfenylalkylpiperzin-derivater, en fremgangsmaate ved fremstilling og et farmasoeytisk preparat.
HUT42770A (en) Process for preparing novel pyrrolo-benzimidazole derivatives, pyrrolo -benzoxazole derivatives and pyrrolo-benzthiazole derivatives and pharmaceutical compositions comprising the same
ATE95698T1 (de) Verhinderung von entzugserscheinungen.
FR2458556B1 (de)
JPS567799A (en) Novel pseudotrisaccharide* its manufacture and use as medicine
DE3277971D1 (en) Acylamino-4-aza-1-adamantanes, process for their preparation and their therapeutic use
FI910059A0 (fi) Kemiska foereningar.
IL60176A0 (en) Xanthine derivatives,processes for the preparation thereof and pharmaceutical compositions containing them
ZA903944B (en) Pyrrolidone derivatives the process for their preparation and the pharmaceutical compositions containing them
DE3060305D1 (en) Cyclophosphathiazenes, process for their preparation and compositions containing them
HUP0001118A2 (hu) N-szubsztituált pirrolidinszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények
JPS5346940A (en) Kanamycin c derivatives effective against resistant bacteria and process for preparation of the same
BR7908996A (pt) Composicao farmaceutica,processo de preparacao de compostos farmaceuticos,processo de prevencao e/ou tratamento de doencas,compostos farmaceutico e processo de prevencao e/ou tratamento de hipocolesterolemia

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee